This systematic review and meta-analysis assesses the prognostic value of pretreatment magnetic resonance imaging (MRI) parameters for oncological outcomes in men undergoing radical prostatectomy.
Category: biotech/medical – Page 115
Vulnerable ALS neurons reveal molecular warning signs before cell death begins
A new study from the Knight Initiative for Brain Resilience researchers may help explain an enduring mystery about amyotrophic lateral sclerosis (ALS): why the disease kills off some of the brain and spinal cord’s movement-controlling neurons while others show greater resilience.
As ALS progresses, more and more of those motor neurons degenerate and die. As a result, patients lose control of their bodies and become unable to breathe. Many people are diagnosed in middle to late adulthood, and most survive only three to five years after diagnosis.
“It’s a cruelly rapid disease,” said Olivia Gautier, a postdoctoral scholar in the lab of Knight Initiative researcher Aaron Gitler, the Stanford Medicine Basic Science Professor and a professor of genetics at Stanford Medicine.
The Placenta: The Organ That Programs Human Health Before Birth | Dr. Perrie O’Tierney-Ginn
Dr. Perrie O’Tierney-Ginn, Ph.D. — Executive Director of the Woman, Mother & Baby Research Institute — Tufts.
Before your heart, brain, or lungs fully developed, one remarkable temporary organ was making decisions that may influence your health for decades. Dr. Perrie O’Tierney-Ginn (https://www.placentascience.com/) explains why the placenta could be the most important organ you’ve never thought about.
Dr. Perrie O’Tierney-Ginn, Ph.D. is Executive Director of the Woman, Mother & Baby Research Institute at Tufts Medical Center (https://www.tuftsmedicine.org/researc… and a Research Associate Professor in both Obstetrics & Gynecology at Tufts University School of Medicine (https://www.tuftsmedicine.org/researc… and the Friedman School of Nutrition Science and Policy (https://nutrition.tufts.edu/academics…).
A self-described \.
Microscale hydrogel fibers could enable imaging inside tiny tissue structures
Researchers have developed light-transmitting hydrogel fibers that are just hundreds of micrometers in diameter. With further development, these soft fibers could one day make it possible to use imaging techniques to detect early breast cancer hidden inside very small breast ducts.
“While traditional, relatively rigid fiber probes may cause mechanical damage when entering narrow, curved or soft tissue spaces, our fibers are very soft with mechanical properties more similar to those of human soft tissues,” said research team leader Yu Zhang from Harbin Engineering University in China. “We made these fibers using a draw-spinning method that was inspired by spider-silk spinning.”
In research appearing in Optics Express, the researchers describe how they tested the new hydrogel fibers by incorporating them into an imaging system and using it to analyze standard pathology-stained breast tissue sections. The imaging system successfully reconstructed the microscopic features used by pathologists to evaluate tumors and, when combined with artificial intelligence algorithms, distinguished tumor subtypes with an accuracy of 93.97%.
Ultra-precise technology can count damaged DNA fragments
The Korea Research Institute of Standards and Science has developed an ultrasensitive immunoassay-based analytical platform that can detect and quantify trace amounts of “Small Excised Damaged DNA (sedDNA)” fragments generated during cellular DNA repair. This technology enables highly sensitive detection with quantification down to the level of several thousand molecules, measuring up to 22 times more DNA fragments than conventional methods. It provides a new analytical foundation for comparing DNA repair capacity between individuals and studying cellular responses to anticancer drugs and carcinogenic agents.
Human DNA is continuously exposed to damage from ultraviolet light, chemical agents, smoking and normal metabolic processes. If such damage is not properly repaired, mutations can accumulate and lead to aging and diseases such as cancer. To maintain genomic stability, cells activate the Nucleotide Excision Repair (NER) system, which removes damaged DNA segments and replaces them with newly synthesized DNA. The small excised DNA fragments generated during this process serve as important indicators of DNA repair efficiency and kinetics, providing a valuable tool for studying disease mechanisms and predicting treatment responses.
Copper-induced cell death stimulates antitumor immune cell responses
A preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Cell, details a connection between the immune system and cuproptosis, a type of copper-induced cell death. The findings suggest a new approach to help overcome resistance to immunotherapy.
The study, led by Boyi Gan, Ph.D., professor of Experimental Radiation Oncology, demonstrates that cancer cells undergoing cuproptosis release signals that activate the immune system. Significantly, this study is among the first to demonstrate that cuproptosis can actively engage the immune system and enhance responses to immunotherapy. In preclinical models, a combination approach of cuproptosis-inducing treatment along with anti-PD-L1 immunotherapy significantly slowed tumor growth.
“This study reveals a previously unrecognized partnership between the immune system and cuproptosis,” Gan said. “Importantly, because the cuproptosis-inducing agents used in our studies already have clinical experience and favorable safety profiles, these findings may offer a practical path toward developing new combination treatments for patients whose cancers no longer respond to immunotherapy.”
The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal
An interesting review on adenoviral cell entry and trafficking. Its discussion of how species B adenoviruses tolerate lower endosomal pH and accumulate in later-endosomal compartments before escaping were particularly intriguing. Link.
Adenoviruses represent exceptional candidates for wide-ranging therapeutic applications, from vectors for gene therapy to oncolytics for cancer treatments. The first ever commercial gene therapy medicine was based on a recombinant adenovirus vector, while most recently, adenoviral vectors have proven critical as vaccine platforms in effectively controlling the global coronavirus pandemic. Here, we discuss factors involved in adenovirus cell binding, entry, and trafficking; how they influence efficiency of adenovirus-based vectors; and how they can be manipulated to enhance efficacy of genetically modified adenoviral variants. We focus particularly on endocytosis and how different adenovirus serotypes employ different endocytic pathways to gain cell entry, and thus, have different intracellular trafficking pathways that subsequently trigger different host antiviral responses.
